Acalisib - CAS 870281-34-8
Catalog number: 870281-34-8
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Acalisib, also known as GS-9820,  is an inhibitor of the beta and delta isoforms of the 110 kDa catalytic subunit of class IA phosphoinositide-3 kinases (PI3K) with potential immunomodulating and antineoplastic activities. p110beta/delta PI3K inhibitor GS-9820 inhibits the activity of PI3K, thereby preventing the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3), which decreases tumor cell proliferation and induces cell death. PI3K-mediated signaling is often dysregulated in cancer cells; the targeted inhibition of PI3K is designed to preserve PI3K signaling in normal, non-neoplastic cells.
Publictions citing BOC Sciences Products
  • >> More
Solid powder
GS-9820; GS9820; GS 9820; CAL-120; CAL 120; CAL120; Acalisib; UNII-OVW60IDW1D.
Current Developer:
Gilead Sciences
1.[Analoghi sintetici dell'ormone di rilascio dell'ormone luteinizzante per il trattamento del carcinoma prostatico localmente avanzato o metastatico: analisi dei costi diretti e indiretti nello scenario italiano].
Fadda V, Maratea D. Recenti Prog Med. 2015 Dec;106(12):634-40. doi: 10.1701/2094.22656.
Riassunto. Introduzione. Gli analoghi sintetici dell'ormone di rilascio dell'ormone luteinizzante (Lh-Rh) sono utilizzati per diverse indicazioni cliniche. I dati di outcome non riportano differenze significative in termini di efficacia tra i diverse analoghi di sintesi Lh-Rh. Materiali e metodi. La ricerca di letteratura è stata eseguita inserendo le seguenti parole chiave nelle biblioteche biomediche online (PubMed) e nei database online delle Agenzie regolatorie (EMA e FDA): "LHRH agonist AND prostatic cancer", "androgen deprivation therapy", "androgen suppression", "buserelin", "leuprorelin", "goserelin", "triptorelin", "degarelix". Nei costi diretti sono stati inclusi i costi relativi alle visite specialistiche di controllo, il costo dell'esame del PSA e il costo del farmaco. Tra i costi indiretti sono stati inclusi le giornate lavorative perse dal paziente. Risultati. Considerando lo schema terapeutico intermittente per tutti i farmaci considerati, il costo di trattamento più basso è attribuibile alla formulazione di Eligard 22,5 mg mentre la spesa più alta si registra con la somministrazione di Firmagon.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PI3K Products

CAS 677338-12-4 PIK-90

(CAS: 677338-12-4)

PIK-90 is a potent PI3K inhibitor.

GSK-2269557 HCl salt
(CAS: 1254036-77-5)

GSK-2269557 is a selective Phosphatidylinositol 3 kinase delta inhibitor originated by GlaxoSmithKline. GSK-2269557 is highly selective for PI3Kδ over the close...

(CAS: 1382979-44-3)

GDC-0084, a PI3K inhibitor, has been found to have probable antineoplastic effect and could pass blood-brain barrier with favourable penetration. It was just li...

CAS 1332075-63-4 PI3k(delta) inhibitor 1

PI3k(delta) inhibitor 1
(CAS: 1332075-63-4)

PI3kδ inhibitor 1 is a potent and selective inhibitor of isoform of PI3Kδ; useful for treating disorders mediated by lipid kinases such as inflammation, immunol...

(CAS: 1268454-23-4)

MLN1117, also known as INK1117, is a PI3Kα inhibitor which could lead to the apoptosis and growth retardation of tumor cells expressed by PI3Kα. IC50: 15 nM.

CAS 1246535-95-4 Desmethyl-VS-5584

(CAS: 1246535-95-4)

Desmethyl-VS-5584, a demethyl analogue of VS-5584, is a PI3K/mTOR kinase inhibitor for the treatment of cancer.

CAS 934526-89-3 Pilaralisib

(CAS: 934526-89-3)

Pilaralisib, also known as XL147, is a methylbenzenesulfonamide derivative that reversibly inhibits class I PI3Ks (IC50s = 39, 36, 23, and 383 nM for p110α, δ, ...

CAS 1276553-09-3 PF-4989216

(CAS: 1276553-09-3)

PF-4989216 is a novel potent and selective PI3K inhibitor. PF-4989216 inhibits the phosphorylation of PI3K downstream molecules and subsequently leads to inhib...

Duvelisib R enantiomer
(CAS: 1261590-48-0)

The R isomer analogue of Duvelisib which is a high selective PI3K δ/γ inhibitor.

CAS 1032568-63-0 Copanlisib

(CAS: 1032568-63-0)

Copanlisib, also known as BAY 80-6946, is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BAY 80-6946 inhibits the activat...

(CAS: 1386874-06-1)

LY3023414, a quinoline derivative, has been found to be a PI3Kα and mTOR inhibitor that could influence cell proliferation and cycle of tumor cells. It was just...

CAS 1383716-33-3 VPS34-IN1

(CAS: 1383716-33-3)

VPS34-IN1 is a potent and selective Vps34 inhibitor with potential anticancer activity. VPS34-IN1 inhibits Vps34 with 25 nM IC50 in vitro.

CAS 900185-02-6 PIK-294

(CAS: 900185-02-6)

PIK-294 is a potent PI3K inhibitor.

CAS 371242-69-2 IC-87114

(CAS: 371242-69-2)

CAS 1202777-78-3 BKM120

(CAS: 1202777-78-3)

BKM120, also called as buparlisib or NVP-BKM120, activity in a range of preclinical cancermodels, specifically inhbits class I PI3K isoforms, which blocks p110α...

CAS 5142-23-4 NSC 66389,3-MA

NSC 66389,3-MA
(CAS: 5142-23-4)

CAS 474012-90-3 CAL-130 Racemate

CAL-130 Racemate
(CAS: 474012-90-3)

CAL-130 racemate is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3Kγ/δ as therapy for T cell acute lymphobla...

CAS 1276105-89-5 CNX-1351

(CAS: 1276105-89-5)

CNX-1351 is a selective covalent Inhibitor of PI3Kα. In an end point assay, CNX-1351 potently inhibited PI3Kα and was 20−400 times less potent against β, γ, an...

(CAS: 1254036-71-9)

GSK2269557, an effective PI3K inhibitor, could be used as against inflammatory and some autoimmune diseases. It has just completes a phase II trial against Asth...

CAS 19870-46-3 1,3-Dicaffeoylquinic acid

1,3-Dicaffeoylquinic acid
(CAS: 19870-46-3)

1,3-Dicaffeoylquinic acid, a caffeoylquinic acid derivative found in artichoke, acts as an anti-hyperlipidemic agent and activates PI3K/Akt.

Chemical Structure

CAS 870281-34-8 Acalisib

Quick Inquiry

Verification code

Featured Items